CLINICAL RESPIRATORY JOURNAL, vol.10, no.1, pp.32-39, 2016 (SCI-Expanded)
BackgroundSarcoidosis is a multisystemic inflammatory granulomatous disease of unknown etiology. No suitable biomarkers are available to evaluate the prognosis of this disease, which still has an unpredictable clinical course. The aim of this study was to evaluate the potential clinical usefulness of hematologic markers.